Ototoxicity and cancer therapy-Reference-Cited by-同舟云学术

Ototoxicity and cancer therapy

Published:2016-02-09 Issue:11 Volume:122 Page:1647-1658
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Landier Wendy¹

Affiliation:

1. Department of Pediatric Hematology/Oncology; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham; Birmingham Alabama

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference84 articles.

1. Low incidence of ototoxicity with continuous infusion of cisplatin in the treatment of pediatric germ cell tumors;Gupta;J Pediatr Hematol Oncol,2006

2. Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales-a report from the Children's Oncology Group;Landier;J Clin Oncol,2014

3. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development;Knight;J Clin Oncol,2005

4. Ototoxicity in children treated for osteosarcoma;Lewis;Pediatr Blood Cancer,2009

5. Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients;Nitz;Oncol Lett,2013

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer;European Archives of Oto-Rhino-Laryngology;2024-09-06

2. Identifying causes of balance impairment and exploring sensory contributions to balance in pediatric oncology: A scoping review;Critical Reviews in Oncology/Hematology;2024-09

3. The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma;Head & Neck;2024-08-02

4. Risk factors associated with ototoxicity in long-term nasopharyngeal carcinoma survivors;Oral Oncology;2024-07

5. Audiological Outcomes of Weekly vs. Triweekly Cisplatin in Head and Neck Cancer with Cochlear-Sparing Intensity-Modulated Radiation Therapy;Cancers;2024-06-14